Cambridge University Press
  • Welcome Guest user
  • Log in | Register
 
Athens log in
Username Password  
Forgot your password?
Subscribe now to view full content , or if you already have an account,
please Login to access this feature
Subscribe now to view full content, or if you already have an account,
please Login to access this feature
Subscribe now to access this feature, or if you already have an account,
please Login.
 
 
  • Advanced search
Cambridge University Press logo
Stahl's Essential Psychopharmacology Online
In Collaboration With NEI
Stahl's Essential Psychopharmacology

Navigation

  • Home
  • The
    Prescriber's Guide
  • Essential
    Psychopharmacology
  • Essential
    Neuropharmacology
  • Other
    Resources
    • Next Generation Antidepressants:
      Beyer and Stahl
  • Stahl's
    Illustrated
  • Drug
    Interaction
 
  • My Bookmarks
  • TOC
  • Carbamazepine
  • Therapeutics
  • Side Effects
  • Dosing and Use
  • Special Populations
  • Art of Psychopharmacology
  • Suggested Reading

Carbamazepine

Therapeutics

Brands

• Tegretol, Carbatrol, Tegretol XR, Equetro, Teril, Timonil, Carbagen, Arbil, Epimaz, Mazepine, Novo-Carbamaz

Generic?

Yes

Class

• Antiepileptic drug (AED)

Commonly Prescribed for

(FDA approved in bold)
• Complex partial seizures with or without secondary generalization (adults and children, monotherapy and adjunctive)
• Generalized tonic-clonic seizures
• Mixed seizure patterns
• Trigeminal neuralgia
• Glossopharyngeal neuralgia
• Lennox-Gastaut syndrome
• Temporal lobe epilepsy (children and adults)
• Neuropathic pain
• Alcohol withdrawal
• Restless legs syndrome
• Bipolar I Disorder (acute manic and mixed episodes)
• Psychosis/Schizophrenia (adjunctive)

How the Drug Works

• Blocks voltage-dependent sodium channels
• Modulates sodium and calcium channels and GABA and glutamate transmission

How Long Until It Works

• Seizures - 2 weeks or less
• Trigeminal neuralgia or neuropathic pain - hours to weeks
• Mania - weeks

If It Works

• Seizures - goal is the remission of seizures. Continue as long as effective and well-tolerated. Consider tapering and slowly stopping after 2 years without seizures, depending on the type of epilepsy
• Trigeminal neuralgia - should dramatically reduce or eliminate attacks, pain may recur. Periodically attempt to reduce to lowest effective dose or discontinue

If It Doesn't Work

• Increase to highest tolerated dose. Subject to autoinduction, meaning that dose requirements can change over time
• Epilepsy: consider changing to another agent, adding a second agent or referral for epilepsy surgery evaluation. Check level if compliance is in question. When adding a second agent, keep drug interactions in mind
• Trigeminal neuralgia: Try an alternative agent. For truly refractory patients referral to tertiary headache center, consider surgical or other procedures

Best Augmenting Combos for Partial Response or Treatment-Resistance

• Epilepsy: drug interactions can complicate multi-drug therapy
• Pain: Can combine with other AEDs (gabapentin or pregabalin) or tricyclic antidepressants

Tests

• Baseline CBC, liver, kidney, and thyroid tests
• Check CBC biweekly for 2 months then every 3 months
• Liver, kidney, and thyroid tests every 6-12 months
• Check sodium levels for symptoms of hyponatremia
 

Current Prices for Individual Subscribers (prices are subject to change)

  Pay-per-view Subscription (48 hours) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447990


$ 40
  Annual Subscription (Single User) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447983


$ 195
  Print + Online Access (One Year, Single User) Unit price

Purchase

Stahl's Essential Psychopharmacology Online

Digital Edition: Print and Online

Once you are sent the Digital Edition, just enter the code from the inside back cover to activate your one-year access to www.stahlonline.org.

ISBN: 9780521746090


$261
For pricing and information for Academic and Medical Libraries, Corporate, Nonprofit or Government Institutions and/or special sales or website sponsorship,

for the Americas please contact:
Cambridge Library Sales,
stahlonline@cambridge.org,
800-221-4512, x6535.

For the rest of the world, please contact:
academicsales@cambridge.org
or call +44 (0) 1223 325741.

Australia and New Zealand
Phone: +61 (3) 8671 1400,
Fax: +61 3 9676 9966,
Email: enquiries@cambridge.edu.au.

 

Footer links

  • About Cambridge University Press
  • About NEI
  • About Dr. Stahl
  • About the Illustrator
  • © Cambridge University Press 2008.
  • Copyright statement
  • Privacy Policy
  • Accessibility
  • Terms of use
  • FAQ
  • Help
  • View Access Details
  • Contact us